Idarucizumab elimination of dabigatran minutes before systemic thrombolysis in acute ischemic stroke

J Neurol Sci. 2016 Nov 15:370:44. doi: 10.1016/j.jns.2016.09.010. Epub 2016 Sep 9.

Authors

Joachim G Schulz¹, Bernard Kreps²

Affiliations

¹ Neurology, CHU Saint-Pierre, Université libre de Bruxelles, Rue Haute 322, 1000 Bruxelles, Belgium. Electronic address: Joachim.Schulz@stpierre-bru.be.
² Emergency Department, CHU Saint-Pierre, Université libre de Bruxelles, Rue Haute 322, 1000 Bruxelles, Belgium.

PMID: 27772783
DOI: 10.1016/j.jns.2016.09.010

No abstract available

Keywords: Anticoagulation; Idarucizumab; Stroke; Thrombolysis.

Publication types

Case Reports
Letter

MeSH terms

Administration, Intravenous
Aged
Antibodies, Monoclonal, Humanized / administration & dosage*
Antithrombins*
Brain Ischemia / drug therapy*
Clinical Trials as Topic
Coagulants / administration & dosage*
Dabigatran / antagonists & inhibitors*
Female
Humans
Stroke / drug therapy*
Thrombolytic Therapy

Substances

Antibodies, Monoclonal, Humanized
Antithrombins
Coagulants
idarucizumab
Dabigatran